Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

While, differences of other variables between the two groups did not reach the significant level (Table 1).Characteristics of study populationVariablesOverall (N = 132)BIOT < 4.7 nmol/L (N = 65)BIOT ≥ 4.7 nmol/L (N = 67)P valueAge (years)74.0 (60.0, 83.0)82.0 (75.0, 86.0)61.0 (52.0, 73.0)< 0.001HbA1c (%)5.9 (5.4, 6.6)6.1 (5.6, 7.2)5.6 (5.3, 6.1)< 0.001Fasting plasma glucose (mmol/L)5.3 (4.8, 6.3)5.5 (4.9, 6.8)5.3 (4.8, 5.9)0.0862-h postprandial glucose (mmol/L)7.4 (6.0, 11.2)9.7 (6.8, 12.1)6.6 (5.5, 8.5)< 0.001Fasting plasma insulin (pmol/L)67.1 (49.7, 102.0)61.9 (47.1, 103.1)73.0 (50.8, 102.0)0.3832-h postprandial insulin (pmol/L)361.4 (235.3, 555.2)362.3 (276.1, 675.7)354.8 (197.8, 500.0)0.324Fasting plasma C-peptide (nmol/L)0.5 (0.4, 0.7)0.5 (0.4, 0.7)0.6 (0.4, 0.7)0.0902-h postprandial C-peptide (nmol/L)1.9 (1.4, 2.5)1.9 (1.4, 2.5)2.0 (1.4, 2.6)0.532HOMA-IR2.4 (1.8, 3.7)2.5 (1.7, 4.0)2.4 (1.8, 3.6)0.779Total cholesterol (mmol/L)4.5 ± 1.04.5 ± 1.14.6 ± 1.00.564Triglyceride (mmol/L)1.5 (1.0, 2.0)1.2 (0.9, 1.9)1.6 (1.0, 2.2)0.012High-density lipoprotein (mmol/L)1.1 (0.9, 1.3)1.1 ± 0.21.1 ± 0.20.636Low-density lipoprotein (mmol/L)2.5 (2.0, 3.0)2.6 ± 0.92.6 ± 0.80.869Very low-density lipoprotein (mmol/L)0.7 (0.5, 1.0)0.7 (0.5, 1.0)0.7 (0.5, 1.0)0.614Lymphocyte (× 103/mm3)1.7 (1.4, 2.2)1.6 (1.4, 1.9)1.8 (1.5, 2.4)0.004Neutrophils (× 103/mm3)3.7 (2.8, 4.5)3.8 (2.7, 4.5)3.5 (3.0, 4.4)0.902Total white blood cell (× 103/mm3)5.9 (5.0, 7.3)6.1 (5.0, 7.2)5.9 (5.2, 7.5)0.617Sex hormone binding protein (nmol/L)40.6 (27.5, 56.2)49.9 ± 21.536.3 ± 17.3< 0.001Albumin (mg/dL)40.9 ± 4.338.5 (36.3, 42.3)43.4 (40.4, 45.0)< 0.001Creatinine (μmol/L)81.0 (69.0, 92.6)81.0 (70.0, 94.5)80.0 (69.0, 91.0)0.436Blood urea nitrogen (mmol/L)5.8 (4.9, 7.2)6.1 (5.3, 7.5)5.4 (4.8, 6.5)0.032Urinary acid (μmol/L)369.4 ± 95.0345.5 ± 101.6392.9 ± 82.10.004Urinary albumin/creatinine (mg/mmol)13.6 (7.6, 24.1)18.8 (11.0, 55.9)10.4 (6.9, 19.6)< 0.00125(OH) vitamin D (nmol/L)15.6 (11.5, 22.1)15.5 (12.3, 21.1)15.7 (10.9, 22.4)0.961Total testosterone (nmol/L)11.1 (8.6, 14.8)9.3 (6.9, 11.5)13.8 (11.0, 16.5)< 0.001Estradiol (pmol/L)132.0 (96.2, 168.0)128.0 (94.0, 164.0)135.0 (106.0, 178.0)0.209Follicle stimulating hormone (IU/L)11.1 (6.3, 19.6)15.7 (9.7, 29.2)7.6 (5.1, 11.3)< 0.001Luteinizing hormone (IU/L)6.7 (4.2, 9.8)8.3 (5.3, 13.7)5.0 (3.6, 7.3)< 0.001Continuous data were presented as mean ± standard deviation (SD) if they met normal or similar normal distribution and two independent samples t tests were performed the differences between the two groups, otherwise they were described as median [1st quartile (Q1), 3rd quartile (Q3)] and Mann: Whitney U tests were applied to compare the differences between the two groupsBIOT bioavailable testosterone, HbA1c glycated hemoglobin, HOMA-IR homeostasis model assessment-insulin resistance; 25(OH) vitamin D 25-hydroxy vitamin D

Source: Characteristics of study population. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Individual and joint association of bioavailable testosterone and aging with neutrophil-to-lymphocyte ratio in Chinese middle-aged and elderly men

Study design awaiting verification · Aging Clinical and Experimental Research · 2019

Original publication title

Individual and joint association of bioavailable testosterone and aging with neutrophil-to-lymphocyte ratio in Chinese middle-aged and elderly men

Jian Zhou; Yaping Wei; Yuan Lan; Jingjing Zuo; Xiangqing Hou; Weikai Hou

© The Author(s) 2019

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

BIOT deficiency and aging were individually and jointly correlated to CSI. Men over 70 years combined with BIOT < 4.7 nmol/L were more like to have higher grade of CSI than others.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background and objectives

Accumulating evidences suggest that chronic systemic inflammation (CSI) is independently associated with large number of major non-communicable chronic diseases (NCDs) ranging from metabolic disorders to cancers, and neutrophil-to-lymphocyte ratio (NLR) has been accepted as a novel, convenient marker for CSI response. Testosterone deficiency in men is linked to high risk of NCDs. This cross-sectional study aimed to investigate the individual and joint association of bioavailable testosterone (BIOT) and aging with NLR.

Source: Background and objectives

Abstract: What methods does the paper describe?

A total of 132 male adults were enrolled during Jan. 2011 and Oct. 2017 in the first affiliated hospital of University of Science and Technology of China. Local weighted regression (LOESS) and multivariable generalized linear regression models were utilized to comprehensively examine the individual and joint association between BIOT and age with NLR.

Source: Methods

Abstract: Results

Obvious linear relationships between NLR and BIOT or age were observed with the LOESS models. NLR was negatively correlated to BIOT after adjusting for some potential confounding factors (P = 0.034). As compared to the lowest quartile of BIOT, the adjusted decrease of NLR for the 2nd, 3rd and 4th quartiles were 0.40, 0.64 and 0.72, respectively. Meanwhile, NLR was observed to be independently correlated to elevated age (P = 0.043). Furthermore, as compared to the counterparts, men over 70 years combined with plasma BIOT less than 4.7 nmol/L had the highest NLR level, which suggested that low BIOT and aging jointly correlated to the level of NLR (P = 0.005).

Source: Results

Abstract: Conclusion

BIOT deficiency and aging were individually and jointly correlated to CSI. Men over 70 years combined with BIOT < 4.7 nmol/L were more like to have higher grade of CSI than others.

Source: Conclusion
Authors’ abstract

Background and objectives

Accumulating evidences suggest that chronic systemic inflammation (CSI) is independently associated with large number of major non-communicable chronic diseases (NCDs) ranging from metabolic disorders to cancers, and neutrophil-to-lymphocyte ratio (NLR) has been accepted as a novel, convenient marker for CSI response. Testosterone deficiency in men is linked to high risk of NCDs. This cross-sectional study aimed to investigate the individual and joint association of bioavailable testosterone (BIOT) and aging with NLR.

Methods

A total of 132 male adults were enrolled during Jan. 2011 and Oct. 2017 in the first affiliated hospital of University of Science and Technology of China. Local weighted regression (LOESS) and multivariable generalized linear regression models were utilized to comprehensively examine the individual and joint association between BIOT and age with NLR.

Results

Obvious linear relationships between NLR and BIOT or age were observed with the LOESS models. NLR was negatively correlated to BIOT after adjusting for some potential confounding factors (P = 0.034). As compared to the lowest quartile of BIOT, the adjusted decrease of NLR for the 2nd, 3rd and 4th quartiles were 0.40, 0.64 and 0.72, respectively. Meanwhile, NLR was observed to be independently correlated to elevated age (P = 0.043). Furthermore, as compared to the counterparts, men over 70 years combined with plasma BIOT less than 4.7 nmol/L had the highest NLR level, which suggested that low BIOT and aging jointly correlated to the level of NLR (P = 0.005).

Conclusion

BIOT deficiency and aging were individually and jointly correlated to CSI. Men over 70 years combined with BIOT < 4.7 nmol/L were more like to have higher grade of CSI than others.

Publication and source details

Original title: Individual and joint association of bioavailable testosterone and aging with neutrophil-to-lymphocyte ratio in Chinese middle-aged and elderly men

Jian Zhou; Yaping Wei; Yuan Lan; Jingjing Zuo; Xiangqing Hou; Weikai Hou

Aging Clinical and Experimental Research · 2019

© The Author(s) 2019https://creativecommons.org/licenses/by/4.0/Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T18:23:07.878663+00:00

DOI: 10.1007/s40520-019-01333-0 · PMC7452919